JuliaHub has recently announced a significant expansion in its commitment to the pharmaceutical sector by doubling its investment in its newly enhanced CFR Part 11-compliant pharmaceutical platform. This move underscores JuliaHub’s dedication to accelerating innovation in drug development and pharmaceutical research through high-performance modeling and simulation.
JuliaHub is excited to announce the appointment of Brad Carman as our new Director of Consulting Services. Brad has over two decades of experience in model-based innovation and design. He brings with him a wealth of experience in modeling and ...
This November, the American Conference on Pharmacometrics (ACoP) is featuring two workshops created by PumasAI – a healthcare intelligence firm with powerful tools for scientific modeling, machine learning, and clinical trial simulation built ...
